SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nicole Ennis Whitehead, Lauren E. Hearn, Michael Marsiske, Maria R. Kahn, William W. Latimer, Awareness of Biologically Confirmed HCV Among a Community Residing Sample of Drug Users in Baltimore City, Journal of Community Health, 2014, 39, 3, 487

    CrossRef

  2. 2
    Ramón San Miguel, Vicente Gimeno-Ballester, Javier Mar, Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literature, Expert Review of Pharmacoeconomics & Outcomes Research, 2014, 14, 3, 387

    CrossRef

  3. 3
    Phil McEwan, Thomas Ward, Samantha Webster, Yong Yuan, Anupama Kalsekar, Kristine Broglio, Isao Kamae, Melanie Quintana, Scott M. Berry, Masahiro Kobayashi, Sachie Inoue, Ann Tang, Hiromitsu Kumada, Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b, Value in Health Regional Issues, 2014, 3, 136

    CrossRef

  4. 4
    Jayant A. Talwalkar, Health services and policy research in hepatology, Current Opinion in Gastroenterology, 2014, 30, 3, 272

    CrossRef

  5. 5
    Sumeet K. Asrani, Gary L. Davis, Impact of Birth Cohort Screening for Hepatitis C, Current Gastroenterology Reports, 2014, 16, 4

    CrossRef

  6. 6
    Liesl M. Hagan, Paul Root Wolpe, Raymond F. Schinazi, Treatment as prevention and cure towards global eradication of hepatitis C virus, Trends in Microbiology, 2013, 21, 12, 625

    CrossRef